Medication-Associated Phthalate Exposure and Childhood Cancer Incidence.
Thomas Patrick AhernLogan G SpectorPer DamkierBuket Öztürk EsenSinna Pilgaard UlrichsenKatrine EriksenTimothy L LashHenrik Toft SørensenDeirdre P Cronin-FentonPublished in: Journal of the National Cancer Institute (2022)
Childhood phthalate exposure was associated with incidence of osteosarcoma and lymphoma before age 19 years. Lingering questions include which specific phthalate(s) are responsible for these associations, by what mechanisms they occur, and to what extent childhood cancer cases could be avoided by reducing or eliminating the phthalate content of medications and other consumer products.